Literature DB >> 15037710

Mevalonate kinase deficiency: Evidence for a phenotypic continuum.

A Simon1, H P H Kremer, R A Wevers, H Scheffer, J G De Jong, J W M Van Der Meer, J P H Drenth.   

Abstract

Both mevalonic aciduria, characterized by psychomotor retardation, cerebellar ataxia, recurrent fever attacks, and death in early childhood, and hyper-immunoglobulin D (hyper-IgD) syndrome, with recurrent fever attacks without neurologic symptoms, are caused by a functional deficiency of mevalonate kinase. In a systematic review of known mevalonate kinase-deficient patients, the authors identified five adults with phenotypic overlap between these two syndromes, which argues for a continuous spectrum of disease. Mevalonate kinase deficiency should be considered in adult patients with fitting neurologic symptoms, with or without periodic fever attacks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037710     DOI: 10.1212/01.wnl.0000115390.33405.f7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

2.  Recurrent fevers and failure to thrive in an infant.

Authors:  David R Scott; Sarah Chan; Johanna Chang; Lori Broderick; Hal M Hoffman
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

3.  Retinitis pigmentosa in mevalonate kinase deficiency.

Authors:  B Balgobind; D Wittebol-Post; J Frenkel
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay.

Authors:  Miao He; Lisa E Kratz; Joshua J Michel; Abbe N Vallejo; Laura Ferris; Richard I Kelley; Jacqueline J Hoover; Drazen Jukic; K Michael Gibson; Lynne A Wolfe; Dhanya Ramachandran; Michael E Zwick; Jerry Vockley
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

5.  Mevalonate kinase deficiency nomenclature.

Authors:  Monique Stoffels; Jos W M van der Meer; Anna Simon
Journal:  Rheumatol Int       Date:  2013-08-07       Impact factor: 2.631

6.  Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.

Authors:  Donato Rigante; Valentina Ansuini; Barbara Bertoni; Anna Lisa Pugliese; Laura Avallone; Gilda Federico; Achille Stabile
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

7.  Intermittent neutropenia as an early feature of mild mevalonate kinase deficiency.

Authors:  Nima Parvaneh; Vahid Ziaee; Mohammad-Hassan Moradinejad; Isabelle Touitou
Journal:  J Clin Immunol       Date:  2013-11-01       Impact factor: 8.317

8.  Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children.

Authors:  E Lainka; U Neudorf; P Lohse; C Timmann; M Bielak; S Stojanov; K Huss; R von Kries; T Niehues
Journal:  Rheumatol Int       Date:  2011-10-30       Impact factor: 2.631

9.  A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil.

Authors:  Adriana A Jesus; Mazen Osman; Clovis A Silva; Peter W Kim; Tuyet-Hang Pham; Massimo Gadina; Barbara Yang; Débora R Bertola; Magda Carneiro-Sampaio; Polly J Ferguson; Blair R Renshaw; Ken Schooley; Michael Brown; Asma Al-Dosari; Jamil Al-Alami; John E Sims; Raphaela Goldbach-Mansky; Hatem El-Shanti
Journal:  Arthritis Rheum       Date:  2011-12

Review 10.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.